基础医学与临床 ›› 2022, Vol. 42 ›› Issue (12): 1906-1910.doi: 10.16352/j.issn.1001-6325.2022.12.1906

• 临床研究 • 上一篇    下一篇

联合检测软骨代谢生物标志物在膝骨关节炎早期诊断中的应用

胡楠1, 张竞1, 王静1, 王沛1, 王婧2, 李自成3, 吴田明4, 王亚红5, 王强6, 何岚1*   

  1. 西安交通大学第一附属医院 1.风湿免疫科; 2.医学影像科,陕西 西安 710061;
    神木市医院 3.影像科; 4.临床检验科; 5.体检中心; 6.骨科, 陕西 神木 719300
  • 收稿日期:2022-04-15 修回日期:2022-10-21 出版日期:2022-12-05 发布日期:2022-11-23
  • 通讯作者: * xajdhl87@mail.xjtu.edu.cn
  • 基金资助:
    国家自然科学基金(82102523);西安交通大学第一附属医院临床研究基金(XJTU1AF-CRF-2020-009)

Combined detection of biomarkers of cartilage metabolism for early diagnosis of knee osteoarthritis

HU Nan1, ZHANG Jing1, WANG Jing1, WANG Pei1, WANG Jing2, LI Zi-cheng3, WU Tian-ming4, WANG Ya-hong5, WANG Qiang6, HE Lan1*   

  1. 1. Department of Rheumatology; 2. Department of Radiography, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061;
    3. Department of Radiography; 4. Clinical Laboratory; 5. Physical Examination Center; 6. Department of Orthopaedics, Shenmu Hospital, Shenmu 719300, China
  • Received:2022-04-15 Revised:2022-10-21 Online:2022-12-05 Published:2022-11-23
  • Contact: * xajdhl87@mail.xjtu.edu.cn

摘要: 目的 评估软骨合成降解中的生物标志物在膝骨关节炎(OA)早期诊断和疾病进展中的临床意义。方法 收集神木市医院门诊及住院部确诊的膝OA患者227例作为膝OA组,选取同期健康体检者178例作为对照组。酶联免疫吸附法检测血清ⅡA型前胶原N端前肽(PⅡANP)、软骨寡聚基质蛋白(COMP)、基质金属蛋白酶-3(MMP-3)和尿Ⅱ型胶原交联C端肽(CTX-Ⅱ)水平,双膝X线正侧位片和SF-36简明健康调查问卷分别评估膝OA受累程度和生活质量。结果 1)与对照组相比,膝OA组血清PⅡANP水平降低,血清COMP、MMP-3和尿CTX-Ⅱ水平均升高(P<0.05);2) 中晚期膝OA组血清PⅡANP低于早期膝OA组及对照组(P<0.05),血清COMP、MMP-3(P<0.05)和尿CTX-Ⅱ均高于早期膝OA组及对照组;3)膝OA组血清PⅡANP水平与K-L分级呈反相关(P<0.05),血清COMP和MMP-3水平与K-L分级呈正相关(P<0.05),血清COMP水平还与年龄呈正相关(P<0.05)。血清PⅡANP水平与精神健康呈反相关(P<0.05);血清COMP水平与生理功能呈反相关(P<0.05),与精神健康呈正相关(P<0.05)。结论 血清PⅡANP、COMP、MMP-3和尿CTX-Ⅱ在膝OA中表达异常,并随疾病严重程度增加而变化,可作为膝OA诊断和疾病进展的参考指标。

关键词: 膝骨关节炎, ⅡA型前胶原N端前肽, 软骨寡聚基质蛋白, 基质金属蛋白酶-3, Ⅱ型胶原交联C端肽

Abstract: Objective To evaluate the clinical significance of biomarkers of cartilage synthesis and degradation for early diagnosis and prognosis of knee osteoarthritis (OA). Methods Two hundred and twenty-seven knee OA outpatients and inpatients in Shenmu Hospital were collected as the knee OA group, while 178 healthy physical examiners as the control group during the same period. Serum pro-collagen ⅡA N-teminal peptide (PⅡANP),cartilage oligomeric matrix protein (COMP), matrix metalloproteinase (MMP-3), and urinary cross-linked C-telopeptide (CTX-Ⅱ)were measured by enzyme-linked immunosorbent assay. The degree of knee OA involvement and quality of life were assessed by antero-posterior and lateral radiographs of both knees and the SF-36 brief health questionnaire, respectively. Results 1)Compared with the control group, the serum PⅡANP level decreased and serum COMP, MMP-3 as well as urinary CTX-Ⅱ increased in the knee OA group (P<0.05). 2)Serum PⅡANP was lower (P<0.05), serum COMP, MMP-3(P<0.05) and urinary CTX-Ⅱ levels were higher in mid-late stage knee OA group than early knee OA group and control group. 3)Serum PⅡANP levels were inversely correlated with K-L grade (P<0.05), serum COMP and MMP-3 levels were positively correlated with K-L grade (P<0.05), and serum COMP level was positively correlated with age (P<0.05). Serum PⅡANP level was negatively correlated with mental health dimension in the SF-36 scale (P<0.05); serum COMP level was negatively correlated with physical function dimension (P<0.05) but positively correlated with mental health dimension (P<0.05). Conclusions The expression of PⅡANP, COMP, MMP-3 and CTX-Ⅱ is abnormal in knee OA and related to the progress of the severity of the disease, so is a potential reference index for the diagnosis and prognosis of knee OA.

Key words: knee osteoarthritis, procollagen ⅡA N-teminal peptide, cartilage oligomeric matrix protein, matrix metalloproteinase, crosslinked C-telopeptide

中图分类号: